BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1282288)

  • 1. Management of severe atopic dermatitis.
    de Prost Y
    Acta Derm Venereol Suppl (Stockh); 1992; 176():117-9. PubMed ID: 1282288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atopic dermatitis: recent therapeutic advances.
    de Prost Y
    Pediatr Dermatol; 1992 Dec; 9(4):386-9. PubMed ID: 1492066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic and prophylactic effects of PUVA photochemotherapy on atopic dermatitis-like lesions in NC/Nga mice.
    Miyauchi-Hashimoto H; Okamoto H; Sugihara A; Horio T
    Photodermatol Photoimmunol Photomed; 2005 Jun; 21(3):125-30. PubMed ID: 15888128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proposed guideline for psoralen photochemotherapy (PUVA) with atopic dermatitis: successful therapeutic effect on severe and intractable cases.
    Yoshiike T; Aikawa Y; Sindhvananda J; Ogawa H
    J Dermatol Sci; 1993 Feb; 5(1):50-3. PubMed ID: 8485113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Topical psoralen photochemotherapy (PUVA therapy) for severe atopic dermatitis (I): An analysis of correlation between effectiveness of PUVA therapy and clinical parameters].
    Minaguchi S; Yoshiike T; Aikawa Y; Nakajima S; Sindhvananda J; Ogawa H
    Nihon Hifuka Gakkai Zasshi; 1990 Nov; 100(12):1251-5. PubMed ID: 2077153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of atopic dermatitis and seborrheic dermatitis with selective UV-phototherapy and PUVA. A comparative study].
    Salo O; Lassus A; Juvakoski T; Kanerva L; Lauharanta J
    Dermatol Monatsschr; 1983 Jun; 169(6):371-5. PubMed ID: 6224707
    [No Abstract]   [Full Text] [Related]  

  • 7. [Photochemotherapy via oral route and atopic dermatitis].
    Binet O; Aron-Brunetiére R; Cunéo M; Césaro MJ
    Ann Dermatol Venereol; 1982; 109(6-7):589-90. PubMed ID: 7187186
    [No Abstract]   [Full Text] [Related]  

  • 8. [How should severe and chronic atopic dermatitis be managed in children?].
    Bernier C
    Ann Dermatol Venereol; 2005 Jan; 132 Spec No 1():1S267-81. PubMed ID: 15984312
    [No Abstract]   [Full Text] [Related]  

  • 9. Onycholysis in a case of atopic eczema treated with PUVA photochemotherapy.
    Morgan JM; Weller R; Adams SJ
    Clin Exp Dermatol; 1992 Jan; 17(1):65-6. PubMed ID: 1424267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immunity in untreated and PUVA treated atopic dermatitis.
    Soppi E; Viander M; Soppi AM; Jansén CT
    J Invest Dermatol; 1982 Oct; 79(4):213-7. PubMed ID: 6215450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine in atopic dermatitis. Modulation in the expression of immunologic markers in lesional skin.
    van Joost T; Kozel MM; Tank B; Troost R; Prens EP
    J Am Acad Dermatol; 1992 Dec; 27(6 Pt 1):922-8. PubMed ID: 1479097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of interleukin-5 and the suppressive effect of cyclosporin A in childhood severe atopic dermatitis.
    Ishii E; Yamamoto S; Sakai R; Hamasaki Y; Miyazaki S
    J Pediatr; 1996 Jan; 128(1):152-5. PubMed ID: 8551410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid flow cytometric assay to detect CD4+ and CD8+ T-helper (Th) 0, Th1 and Th2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy.
    Farrell AM; Antrobus P; Simpson D; Powell S; Chapel HM; Ferry BL
    Br J Dermatol; 2001 Jan; 144(1):24-33. PubMed ID: 11167679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of psoralen photochemotherapy (PUVA) in the treatment of severe atopic eczema in adolescents.
    Atherton DJ; Carabott F; Glover MT; Hawk JL
    Br J Dermatol; 1988 Jun; 118(6):791-5. PubMed ID: 3401414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of atopic dermatitis].
    Bakos N; Szemere P
    Orv Hetil; 1997 May; 138(18):1121-7. PubMed ID: 9182281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis.
    Hijnen DJ; ten Berge O; Timmer-de Mik L; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):85-9. PubMed ID: 17207173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.
    Roekevisch E; Spuls PI; Kuester D; Limpens J; Schmitt J
    J Allergy Clin Immunol; 2014 Feb; 133(2):429-38. PubMed ID: 24269258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of persistent severe atopic dermatitis in 113 Japanese patients with oral psoralen photo-chemotherapy.
    Uetsu N; Horio T
    J Dermatol; 2003 Jun; 30(6):450-7. PubMed ID: 12810992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of glucosamine and low-dose cyclosporine for atopic dermatitis treatment: a randomized, placebo-controlled, double-blind, parallel clinical trial.
    Jin SY; Lim WS; Sung NH; Cheong KA; Lee AY
    Dermatol Ther; 2015; 28(1):44-51. PubMed ID: 25113885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of severe atopic dermatitis in childhood with cyclosporin.
    Zaki I; Emerson R; Allen BR
    Br J Dermatol; 1996 Sep; 135 Suppl 48():21-4. PubMed ID: 8881900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.